Geriatric Oncology

Top Story

Targeted therapies linked to modest survival benefit for elderly patients with renal cell carcinoma

July 2, 2019

Eight important updates for National Cancer Survivor Month

June 29, 2019
June is National Cancer Survivor Month. An estimated 16.9 million cancer survivors live in the United States, and that number is projected to exceed 22 million by 2030.
In the Journals

Walking speed, grip strength predict outcomes among older patients with blood cancers

June 21, 2019
Walking speed appeared to be an important predictor of survival and hospital utilization among older patients with hematologic malignancies, according to results of a…
Meeting NewsPerspective

CX-01 with standard induction chemotherapy shows promise among elderly patients with AML

June 2, 2019
CHICAGO — The low anticoagulant heparin derivative CX-01 combined with standard induction therapy induced encouraging rates of complete response and EFS among…
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »
Video
Meeting News Coverage

VIDEO: CPX-351 improves outcomes for elderly patients with high-risk AML

June 20, 2016
More »